Home » Aeras Global TB Vaccine Foundation, Statens Serum Institut Enter Collaboration
Aeras Global TB Vaccine Foundation, Statens Serum Institut Enter Collaboration
March 31, 2005
The Aeras Global TB Vaccine Foundation of Bethesda, Maryland and Statens Serum Institut (SSI) of Copenhagen, Denmark, announced a new collaboration on the preclinical and clinical development of SSI's tuberculosis (TB) vaccine, HyVac4. Aeras and SSI will form a joint product development team and Aeras will provide funding for its activities. Under the terms of the agreement SSI's subunit HyVac4 TB vaccine candidate will be developed as a booster vaccine to extend the protection of the currently available TB vaccine, Bacillus Calmette-Guerin.
BioSpace (http://www.biospace.com/news_story.cfm?StoryID=19537320&full=1)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct